120 related articles for article (PubMed ID: 27838864)
1. Hetrombopag, a Thrombopoietin Receptor Agonist, Protects Cardiomyocyte Survival from Oxidative Stress Damage as an Enhancer of Stem Cells.
Zhou N; Wang J; Li X; Zhao Y; Sun Y; Zou C
Cardiovasc Drugs Ther; 2016 Dec; 30(6):567-577. PubMed ID: 27838864
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonist.
Xie C; Zhao H; Bao X; Fu H; Lou L
J Cell Mol Med; 2018 Nov; 22(11):5367-5377. PubMed ID: 30156363
[TBL] [Abstract][Full Text] [Related]
3. Safety, Pharmacokinetics and Pharmacodynamics of Hetrombopag Olamine, a Novel TPO-R Agonist, in Healthy Individuals.
Zheng L; Liang MZ; Zeng XL; Li CZ; Zhang YF; Chen XY; Zhu X; Xiang AB
Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):414-422. PubMed ID: 28544774
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
[TBL] [Abstract][Full Text] [Related]
5. Conditioned Medium from Placental Mesenchymal Stem Cells Reduces Oxidative Stress during the Cryopreservation of Ex Vivo Expanded Umbilical Cord Blood Cells.
Kadekar D; Rangole S; Kale V; Limaye L
PLoS One; 2016; 11(10):e0165466. PubMed ID: 27780236
[TBL] [Abstract][Full Text] [Related]
6. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media.
Shaw PH; Olszewski M; Kletzel M
J Hematother Stem Cell Res; 2001 Jun; 10(3):391-403. PubMed ID: 11454314
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.
Mei H; Liu X; Li Y; Zhou H; Feng Y; Gao G; Cheng P; Huang R; Yang L; Hu J; Hou M; Yao Y; Liu L; Wang Y; Wu D; Zhang L; Zheng C; Shen X; Hu Q; Liu J; Jin J; Luo J; Zeng Y; Gao S; Zhang X; Zhou X; Shi Q; Xia R; Xie X; Jiang Z; Gao L; Bai Y; Li Y; Xiong J; Li R; Zou J; Niu T; Yang R; Hu Y
J Hematol Oncol; 2021 Feb; 14(1):37. PubMed ID: 33632264
[TBL] [Abstract][Full Text] [Related]
9. Human cord blood stem cell paracrine factors activate the survival protein kinase Akt and inhibit death protein kinases JNK and p38 in injured cardiomyocytes.
Henning RJ; Sanberg P; Jimenez E
Cytotherapy; 2014 Aug; 16(8):1158-68. PubMed ID: 24820448
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin receptor agonists protect human cardiac myocytes from injury by activation of cell survival pathways.
Baker JE; Su J; Koprowski S; Dhanasekaran A; Aufderheide TP; Gross GJ
J Pharmacol Exp Ther; 2015 Mar; 352(3):429-37. PubMed ID: 25512369
[TBL] [Abstract][Full Text] [Related]
11. Small peptide analogue of SDF-1alpha supports survival of cord blood CD34+ cells in synergy with other cytokines and enhances their ex vivo expansion and engraftment into nonobese diabetic/severe combined immunodeficient mice.
Li K; Chuen CK; Lee SM; Law P; Fok TF; Ng PC; Li CK; Wong D; Merzouk A; Salari H; Gu GJ; Yuen PM
Stem Cells; 2006 Jan; 24(1):55-64. PubMed ID: 16123381
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin alone or in the presence of stem cell factor supports the growth of KIT(CD117)low/ MPL(CD110)+ human mast cells from hematopoietic progenitor cells.
Kirshenbaum AS; Akin C; Goff JP; Metcalfe DD
Exp Hematol; 2005 Apr; 33(4):413-21. PubMed ID: 15781331
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin is synergistic with other cytokines for expansion of cord blood progenitor cells.
Won JH; Cho SD; Park SK; Lee GT; Baick SH; Suh WS; Hong DS; Park HS
J Hematother Stem Cell Res; 2000 Aug; 9(4):465-73. PubMed ID: 10982244
[TBL] [Abstract][Full Text] [Related]
14. [Ex vivo expansion of megakaryocyte progenitor cells for CD133(+) cells derived from human umbilical cord blood].
Wang L; Chen DX; Fang N; Liu ZL; Zhang T; Wan WH; Qi Y; Liu JW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):645-9. PubMed ID: 18549646
[TBL] [Abstract][Full Text] [Related]
15. AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist.
Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T; Nakahata T
Eur J Haematol; 2009 Apr; 82(4):247-54. PubMed ID: 19183407
[TBL] [Abstract][Full Text] [Related]
16. Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells.
Delalat B; Pourfathollah AA; Soleimani M; Mozdarani H; Ghaemi SR; Movassaghpour AA; Kaviani S
Hematology; 2009 Jun; 14(3):125-32. PubMed ID: 19490756
[TBL] [Abstract][Full Text] [Related]
17. [Engraftment of ex vivo expanded mononuclear cells from human umbilical cord blood in NOD/SCID mice].
Xu L; Lin JY; Mao P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1243-6. PubMed ID: 18088476
[TBL] [Abstract][Full Text] [Related]
18. [Effect of different cytokine combinations on the expression of CD49d and CXCR4 and ex vivo expansion of umbilical cord blood mononuclear cells].
Mao P; Xu L; Mo WJ; Yin Y; Xu YL; Lin XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):318-21. PubMed ID: 16638206
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
[TBL] [Abstract][Full Text] [Related]
20. Effect of Food on the Pharmacokinetic and Pharmacodynamic Profiles of Hetrombopag in Healthy Volunteers.
Wang Z; Chen X; Li A; Chen L; Wang Y; Zheng L
Clin Ther; 2020 Dec; 42(12):2280-2288. PubMed ID: 33109386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
